Method and system for enabling detection, and detection of attention deficit hyperactivity disorder (adhd) using spectral data of the brain of selected biochemicals and monitoring treatment
AssigneesDatChem, Griffith University
InventorsCarolyn Mountford, David Crompton
Life of this patent
Estimating the term…
Abstract
Adult attention-deficit/hyperactivity disorder (ADHD) is a neuro-developmental disorder which can be detected by obtaining spectral data of at least one biomarker chemical in the brain and comparing the obtained with a reference level of a subject known to not have ADHD to determine whether the subjects obtained levels are different from the reference level. The effect of treatment of a subject having ADHD can also be monitored.
Claims8
A method for enabling detection of a subject to have attention-deficit/hyperactivity disorder (ADHD), comprising:
- obtaining spectral data of the brain of a subject for at least one of the following biochemicals:
- glutathione,
- glutamine cysteine moiety,
- glycerophosphocholine,
- phosphoryh choline (PC),
- L-isoleucine,
- fucose α (1-6) glycans,
- fucose α (1-2) glycan,
- A phophoethanolamine,
- glucose, and
- Polyethylene (PE);
- and
- comparing the level of the at least one biochemical obtained with the reference level of the biochemical of subjects known to not have ADHD, to determine whether the obtained level is different from the reference level.
A method for monitoring the effectiveness of treatment of a subject having attention-deficit/hyperactivity disorder (ADHD), comprising:
- obtaining spectral data of the brain of a subject for at least one of the following biochemicals:
- glutathione,
- glutamine cysteine moiety,
- glycerophosphocholine,
- phosphoryh choline (PC),
- L-isoleucine,
- fucose α (1-6) glycans,
- fucose α (1-2) glycan,
- A phophoethanolamine,
- glucose, and
- Polyethylene (PE);
- and
- comparing the level of the at least one biochemical obtained with the reference level of the biochemical of subjects known to not have ADHD, to determine whether the obtained level is different from the reference level.
A system for enabling detection of a subject to have attention-deficit/hyperactivity disorder (ADHD), comprising:
- A spectroscopy device for obtaining spectral data of the brain of a subject for at least one of the following biochemicals:
- glutathione,
- glutamine cysteine moiety,
- glycerophosphocholine,
- phosphoryh choline (PC),
- L-isoleucine,
- fucose α (1-6) glycans,
- fucose α (1-2) glycan,
- A phophoethanolamine,
- glucose, and
- Polyethylene (PE);
- and
- a processor for comparing the level of the at least one biochemical obtained with the reference level of the biochemical of subjects known to not have ADHD, to determine whether the obtained level is different from the reference level.
A system for monitoring the effectiveness of treatment of a subject having attention-deficit/hyperactivity disorder (ADHD), comprising:
- obtaining spectral data of the brain of a subject for at least one of the following biochemicals:
- glutathione,
- glutamine cysteine moiety,
- glycerophosphocholine,
- phosphoryh choline (PC),
- L-isoleucine,
- fucose α (1-6) glycans,
- fucose α (1-2) glycan,
- A phophoethanolamine,
- glucose, and
- Polyethylene (PE);
- and
- a processor for comparing the level of the at least one biochemical obtained with the reference level of the biochemical of subjects known to not have ADHD, to determine whether the obtained level is different from the reference level.
Dependencies are inferred from the claim text.